About Attruby™ (acoramidis) INDICATION Attruby is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in ...
Identification of type 2 diabetes- and obesity-associated human β-cells using deep transfer learning
Deep transfer learning methodologies reveal hidden heterogeneity in β-cells driven by type 2 diabetes and obesity.
As SAB initiates its Phase 2b SAFEGUARD study for SAB-142 in new-onset Stage 3 autoimmune T1D patients, EASD provided an opportunity to connect ...
UK biotech Scancell has reported data from a phase 2 trial of its off-the-shelf DNA plasmid vaccine for melanoma that it says backs a swift move to a larger, registrational study. The SCOPE trial of ...
SAB Biotherapeutics (SABS) highlighted multiple presentations made at the 61st Annual Meeting of the European Association for the Study of ...
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Data science certificate programs can help you enter or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback